Top Buy
| Wertpapier ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | 5,25 € | 16,55 € | 215,26 % |
| Intra-Cellular Therapies Inc. | 31 | 0 | 3 | 0 | 66,50 € | 84,73 € | 27,41 % |
| Insmed Inc. | 47 | 0 | 7 | 0 | 69,50 € | 77,15 € | 11,01 % |
| Inogen Inc. | 1 | 2 | 0 | 0 | 11,20 € | 6,53 € | -41,66 % |
| Innoviva Inc. | 6 | 0 | 0 | 0 | 17,50 € | 30,00 € | 71,43 % |
| Immunogen Inc. | 2 | 0 | 0 | 0 | 28,97 € | - | - |
| Heron Therapeutics Inc. | 11 | 1 | 1 | 0 | 1,56 € | 4,63 € | 195,96 % |
| Healthstream Inc. | 4 | 0 | 0 | 0 | 25,80 € | 29,29 € | 13,54 % |
| Geron Corp. | 15 | 0 | 1 | 0 | 3,98 € | 5,52 € | 38,78 % |
| G1 Therapeutics | 19 | 1 | 0 | 0 | 6,43 € | 11,09 € | 72,59 % |
| EyePoint Pharmaceuticals Inc. | 20 | 1 | 2 | 0 | 7,96 € | 27,83 € | 249,72 % |
| Esperion Therapeutis.Inc. | 17 | 1 | 3 | 0 | 1,65 € | 9,27 € | 460,63 % |
| Enanta Pharmaceuticals Inc. | 6 | 3 | 1 | 1 | 11,10 € | 25,11 € | 126,19 % |
| Dynavax Technologies Corp | 4 | 0 | 1 | 0 | 9,67 € | 26,95 € | 178,64 % |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | 23,80 € | 24,97 € | 4,93 % |
| Cytosorbents Corp. | 3 | 0 | 0 | 0 | 0,93 € | 3,25 € | 248,54 % |
| Cytokinetics Inc. | 32 | 1 | 3 | 0 | 49,40 € | 83,56 € | 69,15 % |
| Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 0 | 3,99 € | 6,45 € | 61,92 % |
| Corcept Therapeutics Inc. | 17 | 0 | 0 | 0 | 31,91 € | 36,87 € | 15,54 % |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | 52,00 € | 50,00 € | -3,85 % |
| Codexis Inc. | 7 | 1 | 2 | 0 | 2,59 € | 9,62 € | 271,84 % |
| Chromadex Corp | 10 | 1 | 0 | 0 | 2,96 € | 5,55 € | 87,62 % |
| Cerus Corp. | 4 | 0 | 0 | 0 | 1,92 € | 3,26 € | 69,25 % |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 2 | 0 | 17,93 € | 26,64 € | 48,57 % |
| Brainstorm Cell | 2 | 0 | 0 | 0 | 0,25 € | 1,84 € | 636,27 % |